mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.2 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |